Mrs. Kelley Dawn Dyer, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 110 Dowell Ave, Bellefontaine, OH 43311 Phone: 937-599-3538 Fax: 937-599-4712 |
News Archive
Inovio Pharmaceuticals, Inc. announced it has initiated a phase I trial of its hTERT DNA immunotherapy (INO-1400) alone or in combination with Inovio's IL-12 immune activator (INO-9012) in adults with breast, lung, or pancreatic cancer at high risk of relapse after surgery and other cancer treatments.
It is well-known that the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can spread through respiratory droplets when people sneeze, cough, or talk. Recent evidence has also shown that the virus can hang in the air for hours, hinting at the possibility of airborne transmission.
Kowa Company, Ltd. announced today that the results of a Phase II/III trial showed that high dose peretinoin (NIK-333) given daily for up to 96 weeks reduced the recurrence of hepatocellular carcinoma (HCC) after surgical resection or ablation in hepatitis C virus (HCV) positive patients when compared to placebo.
USAID, "the main U.S. foreign aid agency is in limbo, entering its seventh month without a permanent director despite pledges by the Obama administration to expand development assistance and improve its effectiveness in poor countries," the Washington Post reports in an article examining the agency's prospects and concerns that changes could reduce its clout.
› Verified 2 days ago